Health News Archive - April 23, 2009
CHARENTON-LE-PONT, France, April 23 /PRNewswire-FirstCall/ -- - Strong 10.3% Growth in First-Quarter Revenue Essilor International, the world leader in ophthalmic optics, today announced consolidated revenue of EUR840.4 million for the three months ended March 31, 2009, representing a reported 10.3% increase on the first quarter of 2008.
STOCKHOLM, April 23 /PRNewswire/ -- Pharmalink AB today announced that it has strengthened its Board of Directors as the company's portfolio continues to move towards late stage product development and commercialization.
SANTA MONICA, Calif., April 23 /PRNewswire-FirstCall/ -- Cord Blood America, Inc.
FREMONT, Calif., April 23 /PRNewswire/ -- After a review of several vendors, the University of California Los Angeles (UCLA) has selected the services of Velos and its flagship product, Velos eResearch.
Experts urge sufferers to break the cycle of suffering 'Migraine Million' fundraiser honors one-in-a-million moms CHICAGO, April 23 /PRNewswire-USNewswire/ -- The mother/daughter relationship can give some women headaches -- literally.
National group instrumental in establishing day to honor mom GROVE CITY, Ohio, April 23 /PRNewswire/ -- Mother's Day is a special anniversary for the Fraternal Order of Eagles (http://www.FOE.com) and Grand Madam President Pat Durham.
FOXA1 biomarker predicts likelihood of recurrence and long-term disease-free survival of breast cancer patients; Further strengthens Company's breast cancer menu ALISO VIEJO, Calif., April 23 /PRNewswire-FirstCall/ -- Clarient, Inc., (Nasdaq: CLRT), a premier anatomic pathology and molecular testing services resource for pathologists, oncologists and the pharmaceutical industry, today announced that it has been granted an exclusive intellectual property license from the Indiana University Research and Technology Corporation (IURTC) for the rights to commercialize the FOXA1 biomarker, which predicts the likelihood of recurrence and long-term, disease-free breast cancer survival.
LEVANGER, Norway, April 23 /PRNewswire/ -- HUNT Biosciences, the commercial arm of the HUNT Study and associated biobank today announced the appointment of former GE Healthcare director Per Foss as its new CEO.
MINNEAPOLIS, April 23 /PRNewswire-FirstCall/ -- ATS Medical, Inc.
BRANFORD, Conn., April 23 /PRNewswire-FirstCall/ -- CuraGen Corporation (Nasdaq: CRGN), today reported its financial results for the first quarter of 2009.
- A beast of burden; also, a beast in general.